We are live on ! Find out more
NRXP icon

NRX Pharmaceuticals
NRXP

15 hedge funds and large institutions have $32.4M invested in NRX Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.24% more ownership

Funds ownership: 4.68% → 4.93% (+0.24%)

12% less funds holding

Funds holding: 17 → 15 (-2)

21% less capital invested

Capital invested by funds: $40.9M → $32.4M (-$8.43M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$4.87M
2
VOAM
Vertex One Asset Management
British Columbia, Canada
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$3.94M
2
WAM
Weiss Asset Management
Massachusetts
-$3.55M
3
MSU
Mizuho Securities USA
New York
-$3.5M
4
BFM
Boothbay Fund Management
New York
-$2.09M
5
BCM
Basso Capital Management
Connecticut
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
1
Oxford Asset Management
United Kingdom
$5.64M -$262K -2,500 -4%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$5.47M – – –
MF
3
Magnetar Financial
Illinois
$4.89M +$4.87M +46,500 New
MSU
4
Mizuho Securities USA
New York
$3.21M -$3.5M -33,421 -52%
WCMNY
5
Westchester Capital Management (New York)
New York
$2.59M – – –
WAM
6
Weiss Asset Management
Massachusetts
$2.59M -$3.55M -33,887 -58%
AA
7
AQR Arbitrage
Connecticut
$2.09M – – –
KPF
8
K2 Principal Fund
Ontario, Canada
$2.04M – – –
YCM
9
Yakira Capital Management
Connecticut
$1.75M – – –
BFM
10
Boothbay Fund Management
New York
$1.06M -$2.09M -20,000 -67%
VOAM
11
Vertex One Asset Management
British Columbia, Canada
$1.06M +$1.05M +10,000 New
BCM
12
Bluefin Capital Management
New York
$17K – – –
UBS Group
13
UBS Group
Switzerland
$16K -$18.2K -174 -53%
Carson Wealth (CWM LLC)
14
Carson Wealth (CWM LLC)
Nebraska
$4K – – –
RCM
15
Rivernorth Capital Management
Florida
$2.54K – – –
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
– -$3.94M -37,500 Closed
BCM
17
Basso Capital Management
Connecticut
– -$1.05M -10,000 Closed
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
– -$120K -1,147 Closed
CL
19
CSS LLC
Illinois
– -$31K -293 Closed

NRXP Hedge Fund Activity: Q3 2019 in Review

15 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q3 2019, worth a combined $32.4M — down 21% from $40.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NRXP and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 0 added.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $4.87M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $3.94M sold.

  • 15 institutional investors held NRX Pharmaceuticals (NRXP) as of Q3 2019, down from 17 in Q2 2019.
  • Funds reported $32.4M of NRX Pharmaceuticals stock for Q3 2019, down 21% quarter-over-quarter.
  • 2 funds opened new NRX Pharmaceuticals positions in Q3 2019 and 4 closed out, a net change of -2 holders.
  • The largest NRX Pharmaceuticals buyer in Q3 2019 was Magnetar Financial, an estimated $4.87M added.
  • The largest NRX Pharmaceuticals seller in Q3 2019 was Hudson Bay Capital Management, an estimated $3.94M sold.

Based on aggregated 13F filings for Q3 2019.